Reports
Reports
The global Chondroitin Sulfate market size attained a value of USD 1.25 billion in 2022, driven by increasing prevalence of osteoarthritis. The market is anticipated to grow at a CAGR of 3.6% during the forecast period of 2023-2031 to attain a value of USD 1.72 billion by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Chondroitin sulfate obtained from bovine performs an important role as a flexible connecting matrix between tough filaments of protein in a cartilage to make a polymeric system. In addition to this, chondroitin sulfate by bovine prevents the cartilage from getting degraded by enzymes and free radicals by maintaining an osmotic pressure through absorption of water. Moreover, it adds elasticity and flexibility to the bones. Over the forecast period, the increasing application of bovine chondroitin sulfate in animal feed and pharmaceutical industry is anticipated to propel the segment’s growth.
The market in the North America region is being driven by the growing expansion of the major pharmaceutical and nutraceutical companies in developed countries such as the United States. Moreover, the robust product launches and policies of the government favouring the expansion of pharma sector are likely to provide lucrative opportunities to the market in the coming years.
In the forecast period, the rising prevalence of obesity owing to the growing consumption of fast food in the North America region is anticipated to increase the risk of osteoarthritis. This factor is likely to propel the demand for chondroitin sulfate at a regional level. Furthermore, the chondroitin sulfate market is likely to be aided by the growing demand for personal care and cometic products which will in turn drive the demand for chondroitin sulfate.
Chondroitin sulfate refers to a chemical which is found in the cartilage of humans and animals. Chondroitin sulfate slows the breakdown of joints in diseases such as osteoarthritis. It is also taken as a medicine to support the digestion of body and enhance the function of liver.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on source, the market can be segmented into:
By form, the market has been divided into:
The significant applications of the product include:
The regional markets include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Chondroitin sulfate reverses the degenerative process of osteoarthritis and reduces the pain and discomfort of patients. In this regard, the increasing prevalence of osteoarthritis, coupled with the growing geriatric population is driving the market growth. Chondroitin sulfate is free of side-effects and experts and researchers are investing in scientific studies aimed towards proving the safety and efficacy of the product. Over the forecast period, an anticipated increase in the sales of chondroitin sulfate as a prescription drug and OTC dietary supplement for the treatment of chronic diseases is anticipated to propel the market growth.
The rapid increase in clinical trials aimed towards exploring the potential of chondroitin sulfate are likely to boost the chondroitin sulfate market growth. In the emerging economies, sedentary lifestyles led by the working-class population are also leading to a heightened consumption of chondroitin sulfate to bolster the strength of joints and sensitive areas of body. This factor is likely to garner the application of chondroitin sulfate as a dietary supplement in the nutraceutical industry.
The increasing application of the compound in eye drops for the treatment of red eye and increasing demand for cornea preservation during the cataract surgery are also driving market demand. Another factor increasing the market demand is the growing use of chondroitin sulfate as an oral dose for heart attack.
The report gives a detailed analysis of the following key players in the global market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2016-2022 |
Forecast Period | 2023-2031 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Source |
|
Breakup by Form |
|
Breakup by Application |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Chondroitin Sulfate Market Overview
3.1 Global Chondroitin Sulfate Market Historical Value (2016-2022)
3.2 Global Chondroitin Sulfate Market Forecast Value (2023-2031)
4 Global Chondroitin Sulfate Market Landscape
4.1 Global Chondroitin Sulfate Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Chondroitin Sulfate Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Source
4.2.3 Analysis by Form
4.2.4 Analysis by Application
4.2.5 Analysis by Distribution Channel
5 Global Chondroitin Sulfate Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Chondroitin Sulfate Market Segmentation
6.1 Global Chondroitin Sulfate Market by Product
6.1.1 Market Overview
6.1.2 Food Grade
6.1.3 Pharmaceutical Grade
6.2 Global Chondroitin Sulfate Market by Source
6.2.1 Market Overview
6.2.2 Bovine
6.2.3 Porcine
6.2.4 Poultry
6.2.5 Fish
6.2.6 Sharks
6.2.7 Crocodiles
6.2.8 Others
6.3 Global Chondroitin Sulfate Market by Form
6.3.1 Market Overview
6.3.2 Powder
6.3.3 Tablets
6.3.4 Capsules
6.4 Global Chondroitin Sulfate Market by Application
6.4.1 Market Overview
6.4.2 Pharmaceutical and Nutraceutical
6.4.3 Personal Care and Cosmetics
6.4.4 Animal Feed
6.4.5 Others
6.5 Global Chondroitin Sulfate Market by Distribution Channel
6.5.1 Market Overview
6.5.2 Drug stores and Pharmacies
6.5.3 E-commerce Channels
6.5.4 Other Sales Channel
6.6 Global Chondroitin Sulfate Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Chondroitin Sulfate Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Chondroitin Sulfate Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Chondroitin Sulfate Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Chondroitin Sulfate Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Chondroitin Sulfate Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 BIOIBERICA S.A.U.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 BRF S.A.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Synutra, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Sino Siam Biotechnique Company Limited
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Seikagaku Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Solabia Group
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Stanford Chemicals
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Summit Nutritionals International
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 William Reed Ltd
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Yantai Ruikangda Biochemical Products Co., Ltd
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Qingdao Wantuming Biological Products Co.,Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Sioux Pharm, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Chondroitin Sulfate Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Globally, Chondroitin Sulfate market reached a value of USD 1.25 billion in 2022.
The market is projected to expand at a CAGR of 3.6% from 2022 to 2031, growing to USD 1.72 billion by 2031.
The major regions in the industry examined in-depth in the EMR report are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major drivers of the market include the increasing application of the compound in the pharmaceutical and nutraceutical industry, rising prevalence of osteoarthritis, and growing geriatric population.
The growing research and development activities by researchers to prove the efficacy and safety of the compound are likely to be the key trends in the market.
Swine, bovine, shark, and poultry, among others are the are the different sources based on which the market has been divided.
Powder, and tablet, among others is the market segmentation based on form.
Pharmaceuticals and nutraceuticals, personal care and cosmetics, animal feed, and others, are the significant applications of the product.
The major players in the industry are BIOIBERICA S.A.U., BRF S.A, Synutra, Inc., Sino Siam Biotechnique Company Limited, and Seikagaku Corporation, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.